Announcements Trials
Browse Landscape

Phase

Phase 2 10Phase 3 5Phase 1 4Phase 4 2Phase 1/2 2Phase NA 1Phase EARLY_PHASE1 1

Status

Completed 2Active not recruiting 2Recruiting 1

Sponsor Class

INDUSTRY 3OTHER 2

Study Type

Interventional 5

Sponsor

Cancer Type

Lymphoid 3Plasma cell 1

Conditions

Lymphoma 57Lymphoma, Large B-Cell, Diffuse 40Precursor Cell Lymphoblastic Leukemia-Lymphoma 39Lymphoma, Follicular 33Leukemia 30Lymphoma, Non-Hodgkin 28Burkitt Lymphoma 19Hodgkin Disease 18Neuroblastoma 13Lymphoma, Large-Cell, Immunoblastic 12Central Nervous System Neoplasms 12Sarcoma 10Multiple Myeloma 10Lymphoma, Mantle-Cell 10Rhabdomyosarcoma 9Wilms Tumor 7Lymphoma, T-Cell, Peripheral 7Lymphoma, Large-Cell, Anaplastic 7Lymphoma, B-Cell, Marginal Zone 7Oligodendroglioma 6Neuroectodermal Tumors, Primitive, Peripheral 5Neoplasms, Plasma Cell 5Neoplasms 5Malignant mesenchymal tumor 5Leukemia, Lymphocytic, Chronic, B-Cell 5Brain Neoplasms 5Astrocytoma 5Retinoblastoma 4Recurrence 4Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 4

Interventions

Paclitaxel 20Gemcitabine 16Dexamethasone 16Bevacizumab 16Docetaxel 15Oxaliplatin 14Cyclophosphamide 13Carboplatin 12Capecitabine 12Sorafenib 11Fluorouracil 11Leucovorin 10Cisplatin 10pembrolizumab 9Pemetrexed 9Epoetin Alfa 9venetoclax 8Prednisone 8Fentanyl 8Drug Therapy 8Doxorubicin 8atezolizumab 7Rivaroxaban 7Rituximab 7Darbepoetin alfa 7Anastrozole 7Panitumumab 6Ondansetron 6Morphine 6Irinotecan 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Phase 3 × Neoplasms × Vincristine × Clear all
NCT06191744 2026-05-06

EPCOREâ„¢FL-2

Genmab

Phase 3 Recruiting
1,095 enrolled
Lymphoid

Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Neoplasms

NCT04529772 2026-03-31

ESCALADE

Acerta Pharma BV

Phase 3 Active not recruiting
611 enrolled
Lymphoid

Lymphatic Diseases, Lymphoma, Lymphoma, Non-Hodgkin, Lymphoproliferative Disorders, Neoplasms, Lymphoma, B-Cell, Lymphoma, Large B-Cell, Diffuse

NCT05578976 2025-01-23

EPCORE DLBCL-2

Genmab

Phase 3 Active not recruiting
900 enrolled
Lymphoid

Lymphoma, Non-Hodgkin, Neoplasms, Recurrence, Lymphoma, Large B-Cell, Diffuse

NCT00659269 2016-02-26

A Randomized Phase III Study of Vitamins B6 and B12 to Prevent Chemotherapy-Induced Neuropathy in Cancer Patients

New Mexico Cancer Research Alliance

Phase 3 Completed
319 enrolled 7 charts

Neoplasms, Neuralgia

NCT00083551 2015-11-23

UARK 98-026 TT II: Multiple Myeloma Evaluating Anti-Angiogenesis With Thalidomide and Post-Transplant Consolidation Chemotherapy

University of Arkansas

Phase 3 Completed
668 enrolled 7 charts
Plasma cell

Multiple Myeloma, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡